Literature DB >> 6438279

Malignant peripheral nerve sheath tumors in childhood.

B S Ducatman, B W Scheithauer, D G Piepgras, H M Reiman.   

Abstract

Malignant peripheral nerve sheath tumor (MPNST) is an uncommon sarcoma in the pediatric population; however, its presence should be considered in a child with an enlarging or painful soft-tissue mass. Diagnosis of this neoplasm depends on either the demonstration of its origin within a peripheral nerve or the association with a contiguous neurofibroma. We have identified 16 cases of MPNST involving children 16 years of age or less, which represent 12.8% of the total cases seen at the Mayo Clinic. Most of the lesions arose in children with von Recklinghausen's disease and were associated with a contiguous neurofibromatous component. The mean survival of patients who were known to have died of tumor was only 1.8 years. This sarcoma requires prompt aggressive therapy utilizing wide surgical excision. Because of the association of MPNST with von Recklinghausen's neurofibromatosis, a careful workup and family history should be obtained for the potential prognostic value and for the purpose of genetic counseling.

Entities:  

Mesh:

Year:  1984        PMID: 6438279     DOI: 10.1007/bf00253276

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  23 in total

1.  Malignant neurilemmomas of peripheral nerves.

Authors:  J O VIETA; G T PACK
Journal:  Am J Surg       Date:  1951-10       Impact factor: 2.565

2.  Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant "Triton" tumors).

Authors:  J M Woodruff; N L Chernik; M C Smith; W B Millett; F W Foote
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

3.  Malignant schwannoma. A clinicopathologic study.

Authors:  B C Ghosh; L Ghosh; A G Huvos; J G Fortner
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

4.  Survival in malignant schwannoma. An 18-year study.

Authors:  H R White
Journal:  Cancer       Date:  1971-03       Impact factor: 6.860

Review 5.  Von Recklinghausen neurofibromatosis.

Authors:  V M Riccardi
Journal:  N Engl J Med       Date:  1981-12-31       Impact factor: 91.245

6.  Von Recklinghausen's disease: a clinicopathological study.

Authors:  R D Brasfield; T K Das Gupta
Journal:  Ann Surg       Date:  1972-01       Impact factor: 12.969

7.  Postirradiation neurofibrosarcoma.

Authors:  B S Ducatman; B W Scheithauer
Journal:  Cancer       Date:  1983-03-15       Impact factor: 6.860

8.  Malignant schwannoma--clinical characteristics, survival, and response to therapy.

Authors:  P P Sordillo; L Helson; S I Hajdu; G B Magill; C Kosloff; R B Golbey; E J Beattie
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860

9.  Electron microscopy in the diagnosis of malignant schwannoma.

Authors:  J B Taxy; H Battifora; Y Trujillo; H D Dorfman
Journal:  Cancer       Date:  1981-09-15       Impact factor: 6.860

10.  Combination chemotherapy of metastatic malignant schwannoma with vincristine, adriamycin, cyclophosphamide, and imidazole carboxamide: a case report.

Authors:  R L Goldman; S E Jones; R S Heusinkveld
Journal:  Cancer       Date:  1977-05       Impact factor: 6.860

View more
  7 in total

Review 1.  Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems.

Authors:  Fausto J Rodriguez; Andrew L Folpe; Caterina Giannini; Arie Perry
Journal:  Acta Neuropathol       Date:  2012-02-12       Impact factor: 17.088

2.  Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models.

Authors:  J E DeClue; S Heffelfinger; G Benvenuto; B Ling; S Li; W Rui; W C Vass; D Viskochil; N Ratner
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

3.  Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase.

Authors:  H A Kim; B Ling; N Ratner
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

4.  Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression.

Authors:  D Muir
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

5.  Angiogenic and invasive properties of neurofibroma Schwann cells.

Authors:  S Sheela; V M Riccardi; N Ratner
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

Review 6.  Mesenchymal tumours of the mediastinum--part II.

Authors:  Michael A den Bakker; Alexander Marx; Kiyoshi Mukai; Philipp Ströbel
Journal:  Virchows Arch       Date:  2015-09-10       Impact factor: 4.064

7.  Updates on the diagnosis and treatment of intracranial nerve malignant peripheral nerve sheath tumors.

Authors:  Bénédicte L'heureux-Lebeau; Issam Saliba
Journal:  Onco Targets Ther       Date:  2013-04-26       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.